Citation: E. Jager et al., Perspectives of tumour immunology: antigen-specific immunotherapy of malignant diseases, DEUT MED WO, 126(37), 2001, pp. 1011-1016
Authors:
Westermann, AM
Grosen, EA
Katschinski, DM
Jager, D
Rietbroek, R
Schink, JC
Tiggelaar, CL
Jager, E
Vording, PZVS
Neuman, A
Knuth, A
Van Dijk, JDP
Wiedemann, GJ
Robins, HI
Citation: Am. Westermann et al., Pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer, EUR J CANC, 37(9), 2001, pp. 1111-1117
Citation: D. Jager et al., Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer, J CLIN PATH, 54(9), 2001, pp. 669-674
Authors:
Stohr, A
Heinzelmann, R
Malcoci, A
Jager, D
Citation: A. Stohr et al., Optical heterodyne millimeter-wave generation using 1.55-mu m traveling-wave photodetectors, IEEE MICR T, 49(10), 2001, pp. 1926-1933
Authors:
Jager, D
Stockert, E
Gure, AO
Scanlan, MJ
Karbach, J
Jager, E
Knuth, A
Old, LJ
Chen, YT
Citation: D. Jager et al., Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library, CANCER RES, 61(5), 2001, pp. 2055-2061
Authors:
Baberg, HT
Jager, D
Kahrmann, G
de Zeeuw, J
Bojara, W
Lemke, B
von Dryander, S
Barmeyer, J
Kugler, J
Citation: Ht. Baberg et al., Health promotion and cardiovascular risk factors: Knowledge among 510 cardiologic patients hospitalized in an acute care ward, MED KLIN, 95(2), 2000, pp. 75-80
Authors:
Jager, E
Nagata, Y
Gnjatic, S
Wada, H
Stockert, E
Karbach, J
Dunbar, PR
Lee, SY
Jungbluth, A
Jager, D
Arand, M
Ritter, C
Cerundolo, V
Dupont, B
Chen, YT
Old, LJ
Knuth, A
Citation: E. Jager et al., Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses, P NAS US, 97(9), 2000, pp. 4760-4765
Authors:
Gure, AO
Stockert, E
Scanlan, MJ
Keresztes, RS
Jager, D
Altorki, NK
Old, LJ
Chen, YT
Citation: Ao. Gure et al., Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer, P NAS US, 97(8), 2000, pp. 4198-4203
Authors:
Jager, E
Gnjatic, S
Nagata, Y
Stockert, E
Jager, D
Karbach, J
Neumann, A
Rieckenberg, J
Chen, YT
Ritter, G
Hoffman, E
Arand, M
Old, LJ
Knuth, A
Citation: E. Jager et al., Induction of primary NY-ESO-1 immunity: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers, P NAS US, 97(22), 2000, pp. 12198-12203
Authors:
Jager, E
Jager, D
Karbach, J
Chen, YT
Ritter, G
Nagata, Y
Gnjatic, S
Stockert, E
Arand, M
Old, LJ
Knuth, A
Citation: E. Jager et al., Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB40101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma, J EXP MED, 191(4), 2000, pp. 625-630
Authors:
Jager, E
Maeurer, M
Hohn, H
Karbach, J
Jager, D
Zidianakis, Z
Bakhshandeh-Bath, A
Orth, J
Neukirch, C
Necker, A
Reichert, TE
Knuth, A
Citation: E. Jager et al., Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanomapatient responding to continued immunization with melanoma-associated peptides, INT J CANC, 86(4), 2000, pp. 538-547